Fig. 5From: The efficacy of thymosin α1 as immunomodulatory treatment for sepsis: a systematic review of randomized controlled trialsThe effect of thymosin α1 on HLA-DR levels. Eight studies including 721 patients reported the level of HLA-DR. There was a significant difference in HLA-DR between thymosin α1 and control groupBack to article page